Arkolith/Insider Trading/MAIA/Form 4

Smith Stan

DirectorMAIA Biotechnology, Inc. (MAIA) · full profile →Form 4 · filed Dec 13, 2024
Net Buying
Open-Market Buys
$47K
Open-Market Sells
$0
Net Open-Market Flow
$47K
Transactions
2
1 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Dec 13, 2024Buy(P)25K$1.87$47K1.1M

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Dec 13, 2024Buy(P)25K$2.08$52K25K

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001127602-24-029383) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML